Related Experiment Video

Updated: May 25, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:07

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

Sex-gender differences in diabetes vascular complications and treatment

Flavia Franconi1, Ilaria Campesi, Stefano Occhioni

  • 1Center for Biotechnology Development and Biodiversity Research and Department of Biomedical Science, University of Sassari, Italy.

Endocrine, Metabolic & Immune Disorders Drug Targets
|January 13, 2012
PubMed

Insights

Diabetes significantly increases cardiovascular disease risk, particularly in women. Research must address sex and gender differences for equitable health outcomes and targeted treatments.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Sex and Gender in Health

Background:

  • Diabetes mellitus and cardiovascular diseases (CVD) are closely linked, with diabetes being a major CVD risk factor.
  • Diabetic women face a disproportionately higher cardiovascular risk (3.5-fold) compared to diabetic men (2.1-fold).
  • Sex-specific hormonal influences on glucose metabolism suggest gender-based mechanisms in diabetic complications.

Purpose of the Study:

  • To highlight the unmet need for sex- and gender-specific therapeutic approaches in managing diabetes and its complications.
  • To emphasize the importance of sex-gender differences in disease progression and treatment efficacy, as observed in renal diseases.
  • To advocate for sex-gender-inclusive research methodologies to achieve health equity.

Main Methods:

  • Review of epidemiological data, including Framingham study findings on sex differences in cardiovascular risk.
  • Analysis of molecular pathways related to insulin resistance and their potential sex-specific roles.
  • Critique of current clinical trial designs for their exclusion of fertile women and lack of focus on sex-gender differences.

Main Results:

  • Diabetic women exhibit a significantly higher cardiovascular risk increase than men.
  • Females may experience faster progression of diabetic complications like renal disease.
  • Women often derive less benefit from treatments compared to men.
  • Current research and trials inadequately address sex-gender disparities.

Conclusions:

  • Sex and gender significantly impact the development and progression of diabetic complications and cardiovascular risk.
  • There is a critical need for sex- and gender-specific research, including epidemiological reports and clinical trials.
  • Future randomized controlled trials must incorporate sex-gender considerations to advance evidence-based medicine and ensure health equity.

More Related Videos

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...